FDA is urged to increase regulatory oversight over tanning beds

12/14/2012 | Hill, The

The American Cancer Society is calling on federal officials to subject tanning beds to greater FDA oversight due to findings that the devices are associated with an increased risk of skin cancer. Makers of tanning beds contend there has been no proof of a link between their products and fatal cancers.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN